Department of Defense September 6, 2011 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Meeting of the Uniform Formulary Beneficiary Advisory Panel; Amended Meeting Notice
Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C. Appendix 2) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b), and 41 CFR 102-3.150 the Department of Defense announces a change to the previously announced meeting of the Uniform Formulary Beneficiary Advisory Panel. The meeting notice published in the August 16, 2011 edition of the Federal Register (76 FR 50720) is changed to reflect a change in the meeting agenda. The current agenda item, Multiple Sclerosis is replaced with Phosphodiesterase-5 Inhibitors (PDE-5s). The Panel will review and comment on the Phosphodiesterase-5 Inhibitors, Non-Steroidal Anti-Inflammatory Drugs, Contraceptives, Designated Newly Approved Drugs in already reviewed classes and Pertinent Utilization Management Issues. All other aspects of the previously announced meeting agenda remain valid.
Privacy Act of 1974; System of Records
The Department of the Army proposes to add a system of records to its inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
